Persévérance

What Persévérance does

Persévérance is a French fonds de dotation (endowment fund) created in September 2024 and officially launched in December 2024 as the unique fundraising vehicle for the Institut de Cancérologie de l'Ouest (ICO), a European Reference Center in oncology located in Angers and Saint-Herblain. Registered under SIREN 933 209 231, governed by a 14-member volunteer board chaired by Pr Mario Campone (ICO Director General), and operated by a four-person professional team led by Déléguée Générale Laurence Sécher, Persévérance channels individual donations, recurring gifts, corporate mécénat, memorial contributions, legacy gifts (legs, donations, assurance-vie), and IFI donations toward ICO's cancer research, innovation, prevention, and patient care programs.

Funded initiatives span six distinct categories: (1) research platforms including the EPICO epigenetics platform (PromethION sequencer, digital PCR) and the constitutional genetics platform focused on BRCA1/BRCA2/PALB2 mutations (2nd-largest oncogenetics consultation volume in France); (2) cutting-edge technology such as FLASH radiotherapy (FLASHMOD) and next-generation MRI at ICO Angers (~5,000 exams/year capacity); (3) personalized prevention via the Interception program; (4) medical equipment including 3D mammography (€184,000 raised in 2023); (5) young researcher support; and (6) patient care programs (pediatric accompaniment, first-cure kits). Persévérance markets a six-tier donor recognition program (Donateurs to Grands Philanthropes, €1,000 to €150,000+) with French tax deductions of 66% (individuals), 60% (corporations), and 75% (IFI), and discloses management fees held below 15%.

Revenue mechanics rely on six streams: one-time donations, recurring monthly gifts, corporate philanthropy partnerships (Groupama Loire Bretagne, LMWR, Groupe Eram, Sodebo, Gulfstream Communication, La Perle des Dieux, AXA), in-memoriam donations, legacy gifts, and IFI donations. Distribution combines an online donation platform (dons.perseverance-ico.com), personalized crowdfunding pages (soutien.perseverance-ico.com), postal check donations, in-person appointments, and corporate partnerships. Reach extends across Pays de la Loire (Maine-et-Loire, Loire-Atlantique, Vendée) through charity events (La Baule Rose, golf/tennis/padel tournaments, DAG race, Plantu auction), social media (Instagram for Inst'AJA), newsletter, and partnership channels with patient associations (AIDA, Comité Féminin 44/49, UFOLEP 44, Cancer Espoir 49, Nonna Rosa, Les Amis de DAG) and educational institutions (Fondation Audencia).

Name

Persévérance

Legal name

PERSEVERANCE, Le fonds de dotation de l'ICO

Website

https://perseverance-ico.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Persévérance is the French fonds de dotation (endowment fund) launched in 2024 as the unique fundraising vehicle for the Institut de Cancérologie de l'Ouest, channeling individual, corporate, and legacy donations toward cancer research, prevention, and patient care across the Pays de la Loire region.

Ownership category

akta.pro rank

Product category

Healthcare Philanthropy and Endowment Fund Services

NAICS

Voluntary Health Organizations (813212), Grantmaking and Giving Services (8132)

SIC

Services-Social Services (8300)

akta.pro primary industry

Grantmaking & Philanthropic Funds (Institutional Donors) (BPADAOAB)

Keywords

• Cancer research funding
• Medical philanthropy services
• Endowment fund management
• Oncology patient support
• Charitable donation platform

Headquarters

HQ city

Angers

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Others

Revenue model

1. One-time Donations (Don ponctuel): Immediate contributions allowing rapid response to needs: financing cutting-edge equipment, supporting ongoing research, improving patient daily life. Can be dedicated to specific pathologies or associated with national mobilization campaigns (Juin Vert, Septembre en Or, Octobre Rose, Movember).
2. Regular Recurring Donations (Don régulier): Monthly commitment providing long-term visibility for project planning and sustainability. Enables building a reliable and continuous solidarity chain.
3. Corporate Philanthropy/Mécénat: Corporate sponsorship supporting research development, innovation, patient quality of life, and equipment acquisition. Provides RSE/CSR alignment, 60% tax deduction (up to 0.5% of HT turnover), and cohésion interne for company teams. Companies include Groupama Loire Bretagne, LMWR, Groupe Eram, Sodebo, Gulfstream Communication, La Perle des Dieux.
4. In Memoriam/Memorial Donations: Donations made in memory of deceased loved ones, alternative to flowers and traditional plaques. Used for research, innovation, patient support, and caregiver assistance projects.
5. Deferred Giving (Legs, Donations, Life Insurance): Major legacy gifts including testamentary bequests, lifetime donations, and life insurance policies. Major resources enabling strategic projects, long-term research, and patient care improvements. Exempt from succession or transfer taxes.
6. IFI Donations: Donations through Impôt sur la Fortune Immobilière (Wealth Tax on Real Estate) with 75% tax deduction.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels9 records

Core offering

Persévérance is a non-profit endowment fund (fonds de dotation) that serves as the dedicated fundraising vehicle for the Institut de Cancérologie de l'Ouest (ICO). It collects and channels donations toward cancer research, innovation, prevention, and patient care projects at ICO, including medical equipment acquisition, research platforms, young researcher support, and patient support programs. The fund offers one-time, recurring, memorial, corporate, IFI, and legacy giving instruments, with management fees capped at under 15%.

Product overview

Persévérance is a professional fundraising endowment fund (fonds de dotation) for the Institut de Cancérologie de l'Ouest (ICO), providing a unified platform for cancer research, prevention, and patient care donations. The organization supports multiple distinct programs including: personalized cancer prevention (Interception), medical equipment (3D mammography, MRI), research platforms (constitutional genetics, epigenetics EPICO, FLASH radiotherapy), young researcher support, patient support services (pediatric accompaniment, first chemotherapy kits), and digital prevention (Inst'AJA on Instagram). Donors can contribute through one-time/recurring donations, corporate patronage, memorial gifts, or legacy bequests via the online donation platform.

Differentiator

Problem solved

Functional benefit

Brands

• Persévérance: The main brand name of the fonds de dotation, representing the charitable organization dedicated to supporting cancer research and patient care at ICO.

Products and services

• Online Donation Collection Platform Secure online donation platform (dons.perseverance-ico.com) enabling one-time and recurring donations, memorial (In Memoriam), corporate patronage, legacy gifts, and IFI donations for cancer research at ICO.
• Dedicated Personal Fundraising / Crowdfunding Pages Personalized fundraising pages (soutien.perseverance-ico.com) that allow individuals to create crowdfunding-style collections for personal events such as birthdays, retirements, or memorial tributes, with proceeds directed to ICO.
• Interception — Personalized Cancer Prevention Program Personalized prevention program for individuals at increased risk of developing certain cancers, including one-stop-day specialized consultations, prevention workshops, personalized advice, health evaluations, nutritional support, adapted physical activity, and smoking cessation assistance.
• Constitutional Genetics Platform (Oncogenetics) Constitutional genetics platform dedicated to identifying and preventing hereditary cancers, particularly breast and ovarian cancer, by strengthening identification of genetic risk mutations (BRCA1, BRCA2, PALB2) using high-throughput sequencing, CRISPR, MLPA, and advanced bioinformatics. Serves patients and families across the Pays de la Loire region.
• EPICO Epigenetics Platform Epigenetics platform for understanding, predicting, and treating cancer through real-time blood sample analysis, enabling ultra-personalized medicine and treatment adaptation. Equipped with PromethION 3rd-generation sequencer, QIACUBE CONNECT, QUBIT 4, and digital PCR automates.
• FLASHMOD Flash Radiotherapy Research FLASH radiotherapy research project developing innovative treatment methods capable of delivering very high doses in a fraction of a second, reducing side effects and protecting healthy tissue, with focus on pediatric cancers.
• Next-Generation MRI Angers (Medical Equipment Project) Next-generation MRI installation project at ICO Angers for improved cancer diagnosis, enhanced radiotherapy precision, and comprehensive patient care. Capable of approximately 5,000 examinations per year (80% diagnosis, 20% radiotherapy).
• 3D Mammography Acquisition Latest generation 3D mammograph enabling 3D visualization of the breast with unique resolution essential for early detection of lesions sometimes invisible to the naked eye.
• Inst'AJA Digital Prevention Program Instagram-based prevention initiative providing reliable medical information for adolescents and young adults affected by cancer or in remission, featuring short scientifically validated pedagogical videos co-created with patients and healthcare professionals.
• Young Researchers Support Program Support program for young researchers, including thesis funding for AI and genetics research, and studies on treatment resistance in triple-negative breast cancer.
• Pediatric Patient Accompaniment Program Pediatric support program using stuffed animals as pedagogical tools to reduce children's anxiety during radiotherapy treatment at ICO Saint-Herblain.
• Treatment Sequelae Program Program to prevent and alleviate cancer treatment sequelae including cardiac effects and pain management through cardio-oncology testing and photobiomodulation therapy.
• Sac 1ère Cure (First Treatment Kit) Educational kit given to chemotherapy patients at their first treatment session, containing useful and reassuring items including recipe books, skincare products, physical activity cards, and adapted lubricants.
• Legacy Giving (Legs, Donations, Life Insurance) Major legacy gift program including testamentary bequests, lifetime donations, and life insurance policies, exempt from succession or transfer taxes, enabling strategic long-term research and patient care projects.
• Corporate Mécénat Partnerships Custom-built corporate sponsorship arrangements supporting cancer research, innovation, patient quality of life, and equipment acquisition, with 60% corporate tax deduction (up to 0.5% of HT turnover).

Quantifiable outcome

• 50,000+ patients served annually through ICO
• +4 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

16 partnerships are on record, tiered core and minor.

• Groupama Loire BretagnecoreGTM or Marketing PartnerInsurance company listed as corporate patron (mécène) supporting Persévérance's cancer research and patient care initiatives. Logo displayed on partners page.
• LMWRcoreTechnology or IntegrationCommunication agency that designed and developed the Persévérance website. Listed as corporate patron supporting the foundation. Role includes ongoing website services.
• Groupe EramcoreGTM or Marketing PartnerRetail/manufacturing company whose CEO Xavier Biotteau serves on Persévérance's governance board. Listed as corporate patron.
• SodebocoreGTM or Marketing PartnerFood service company listed as corporate patron supporting cancer research and patient care projects.
• Gulfstream CommunicationcoreGTM or Marketing PartnerCommunication company whose CEO Vincent Houdou serves on Persévérance's governance board as PDG. Listed as corporate patron.
• La Perle des DieuxminorGTM or Marketing PartnerFood/agriculture company listed as corporate patron supporting Persévérance.
• Fondation AudenciacoreStrategic or Co-development PartnerCo-organizer with Persévérance of Plantu charity auction (September 2026) at Mediacampus Audencia in Nantes. Partnership combines culture, higher education, and medical research. Funds support genetics platform at ICO and youth prevention actions at Audencia Foundation.
• K'pital ConseilminorGTM or Marketing PartnerListed as partner supporting the Plantu charity auction event.
• Association Cancer Espoir 49coreGTM or Marketing PartnerPatient support association that made generous donation providing teddy bears for young radiotherapy patients at ICO Saint-Herblain. Teddy bears used as pedagogical tools to reduce children's anxiety and facilitate communication with medical teams.
• Association AIDAcoreStrategic or Co-development PartnerNational reference association for accompanying adolescents and young adults with cancer. Co-developer of Inst'AJA project with ICO, creating scientifically validated cancer prevention content for Instagram targeting AJA patients and survivors.
• Comité Féminin 44coreGTM or Marketing PartnerAssociation dedicated to breast cancer prevention and early screening. Organizer of La Baule Rose 2026 events (padel, tennis, golf, running/walking) in October, with proceeds supporting ICO research and patient actions.
• Comité Féminin 49coreGTM or Marketing PartnerAssociation dedicated to breast cancer prevention. Organizer of motorcycle rally (Rando Moto) and other October Rose events in Maine-et-Loire department, with funds supporting ICO projects.
• UFOLEP 44minorGTM or Marketing PartnerSports association organizing Marche Rose (Pink March) event in Saint-Herblain, with donations supporting ICO patient projects.
• Les Amis de DAGminorGTM or Marketing PartnerAssociation organizing the DAG race (5th and final edition) in memory of Philippe Daguillon, supporting cancer research and patient care at ICO.
• Association Nonna RosaminorGTM or Marketing PartnerAssociation organizing guinguette (outdoor dining) solidarity event in Notre-Dame-des-Landes, with proceeds supporting Persévérance/ICO.
• Institut Gustave RoussycoreStrategic or Co-development PartnerPremier French cancer center that originally developed the Interception program, now being deployed at ICO and other Centres de Lutte Contre le Cancer. ICO officially joined the national Interception program in May 2026.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Institut Bergonié: CLCC in Bordeaux, part of the same Unicancer network as ICO, with parallel cancer research and patient care fundraising needs. Comparable as a regional French cancer center fundraising counterpart.
• Centre Léon Bérard: CLCC in Lyon (Unicancer network, like ICO) with its own cancer research and patient care fundraising. Direct comparable in terms of regional comprehensive cancer center with associated fundraising operations.
• Fondation Toulouse Cancer Santé: Regional cancer-focused foundation supporting research and care in the Toulouse area. Comparable in scope and mission to Persévérance's regional approach to funding cancer projects.
• Institut du Cancer de Montpellier (ICM): CLCC in Montpellier within the same Unicancer network as ICO, with overlapping research platforms (oncogenetics, immunotherapy) and similar fundraising needs. Comparable as a regional Unicancer fundraising peer.
• Fondation Gustave Roussy: Fundraising arm of France's leading cancer center and Persévérance's named national partner on the Interception program. Operates the same fonds de dotation / foundation model to support a French Comprehensive Cancer Center, making it the closest structural comparable.

Broad incumbents

• Institut Curie: Major French cancer research and treatment center with a large, established philanthropic operation. Pr Anne Vincent Salomon (Institut Curie) sits on Persévérance's board, evidencing direct ties; operates at vastly larger national scale.
• Fondation ARC pour la recherche sur le cancer: National foundation funding cancer research across France, with broad brand recognition and major-gift capacity. Competes with Persévérance for research-oriented donors in the same French oncology funding pool.
• Ligue contre le cancer: France's largest national cancer charity, with departmental committees (including in Maine-et-Loire and Loire-Atlantique where Persévérance operates). Competes directly for individual and corporate donations in the same regional catchment.
• Fondation de France: France's largest philanthropic umbrella organization, operating cancer and health programs as one of many cause areas. Comparable as a French grantmaking entity but operates at national scale across many causes.

Regional players

• Centre Paul Strauss (CLCC Strasbourg): CLCC serving eastern France (Alsace) within the same Unicancer network as ICO. Comparable as another Unicancer fundraising counterpart but in a non-overlapping regional geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/perseverance.ico
• LinkedInlinkedin.com/company/pers%C3%A9v%C3%A9rance-fondsdedotation
• Instagraminstagram.com/perseverance_ico

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Persévérance